SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Influx Healthtech Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93847

INE0MYZ01012

36.3489357

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFLUX

44.12

589.41

EPS(TTM)

Face Value()

Div & Yield %

5.77

Back

Dabur India consolidated net profit rises 7.20% in the December 2025 quarter

Jan 29,2026

Net profit of Dabur India rose 7.20% to Rs 559.97 crore in the quarter ended December 2025 as against Rs 522.38 crore during the previous quarter ended December 2024. Sales rose 6.06% to Rs 3558.65 crore in the quarter ended December 2025 as against Rs 3355.25 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	3558.65	3355.25	6
OPM %	20.62	20.32	-
PBDT	843.35	766.22	10
PBT	726.16	657.58	10
NP	559.97	522.38	7

76,664.21 -999.79 ( -1.29%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)